About Marius Pharmaceuticals
Marius Pharmaceuticals is a Healthcare company based in Raleigh (United States) founded in 2017 by Himanshu H Shah and Om Dhingra. A proprietary oral testosterone replacement therapy platform is developed. It operates on a Direct-to-Consumer (D2C) model. Marius Pharmaceuticals has raised $11.61 million across 2 funding rounds. Its chief executive, as recorded, is Shalin Y Shah. Marius Pharmaceuticals offers products and services including KYZATREX. Its focus areas include Pharmaceuticals and Hormone Therapy. Its competitors include Auxilium Pharmaceuticals, Xanodyne Pharmaceuticals and Microchips Biotech; 3 of its 3 listed competitors have raised funding.
Company details
Marius Pharmaceuticals is dedicated to revolutionizing hormone health through science-backed therapies. The company addresses testosterone deficiency, impacting metabolic vitality and well-being for both men and women. Solutions are developed to improve conditions like obesity, type 2 diabetes, and menopausal symptoms in women. Research initiatives are supported to explore hormone imbalances across various comorbidities and patient populations. Innovative oral testosterone therapy, such as KYZATREX, is provided to treat adult men with low testosterone levels due to specific medical conditions.
- Headquarters Raleigh, United States
- Founders Himanshu H Shah, Om Dhingra
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website mariuspharma.com
- Social LinkedIn
- Legal Name Marius Pharmaceuticals
- Total Equity Funding$11.61M (USD)
in 2 rounds
- Latest Funding Round$6.01M (USD), Series B
Oct 2021
Products & Services of Marius Pharmaceuticals
Marius Pharmaceuticals offers a comprehensive portfolio of products and services, including KYZATREX.
Oral testosterone therapy for men with deficiency issues.
Funding Insights of Marius Pharmaceuticals
Marius Pharmaceuticals has successfully raised a total of $11.61M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $6.01 million completed in October 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $11.61M
- Total Rounds 2
- Last Round Series B — $6.01M
- First Round $5.6M
(May 2019)
All 2 funding rounds of Marius Pharmaceuticals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2021 | $6.01M | Series B | – | – | – |
| May 2019 | $5.6M | Series B | – | – | – |
People of Marius Pharmaceuticals
13 people are tracked at Marius Pharmaceuticals (8 in leadership, 1 in board & advisors, 4 in team).
| Name | Role | Group |
|---|---|---|
Himanshu H Shah | Co-Founder | Leadership |
Amit Shah | COO and Member of the Board | Leadership |
Shalin Y Shah | CEO | Leadership |
Om Dhingra | Co-Founder | Leadership |
Richard Callaghan | Sr. VP, Marketing | Leadership |
Jessica Tubbs | VP of Sales and Marketing at Marius Pharmaceuticals | Leadership |
Nita N. | Director, Quality Assurance and Regulatory | Leadership |
Polly Sawyer | Sr. VP Of Commercial Development | Leadership |
Ramesh Mahalingam | Director | Board & advisors |
Jami Swanky | Sales Operations &Training Manager | Team |
Brandon Keip | Territory Sales Manager | Team |
Lilly Washburn | Senior Manager, Marketing & Communications | Team |
Michael Strom | Senior Manager of Finance and HR | Team |
Complete people profiles for Marius Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Marius Pharmaceuticals
3 dated milestones of Marius Pharmaceuticals across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Marius Pharmaceuticals is founded.
- Funding First funding round of $5.6M.
- Funding Latest funding round, Series B, of $6.0M.
Competitors of Marius Pharmaceuticals
Marius Pharmaceuticals has 3 listed competitors in our database, 3 of them funded. They include Auxilium Pharmaceuticals, Xanodyne Pharmaceuticals and Microchips Biotech.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| auxilium.com | 1999 | Philadelphia, United States | $43M | Developer of therapeutics and drug-device combinations for urology and sexual health | ||
| xanodyne.com | 2001 | Florence, United States | $175.78M | 6 | Developer of drugs for women's health and pain management | |
| microchipsbiotech.com | 1999 | Lexington, United States | $118.61M | 10 | Microchip implants for wireless drug delivery are developed. |
Detailed competitors of Marius Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Marius Pharmaceuticals
The website of Marius Pharmaceuticals (mariuspharma.com) receives about 3.9K visits a month.
- Monthly visits3.9K
▲ 0.6% vs previous month
Top companies in Women's Health & Fertility
3 companies that operate in the same segment as Marius Pharmaceuticals (Women's Health & Fertility) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of cell-free DNA testing for oncology, women’s health, and organ health | 2004 | Redwood City, California, United States | USD 152.1 M | USD 2.31 B | 4,430 | |
Therapeutics for women's healthcare are developed and offered. | 1997 | Princeton, New Jersey, United States | USD 123.06 M | USD 19.59 M | ||
Provider of cell-free cancer liquid biopsy test | 2015 | San Francisco, California, United States | USD 388.62 M | 861 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Marius Pharmaceuticals
Complete news archive for Marius Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Marius Pharmaceuticals
Marius Pharmaceuticals was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Marius Pharmaceuticals is headquartered in Raleigh, United States. It is registered at Raleigh, North Carolina, United States.
Shalin Y Shah is the CEO of Marius Pharmaceuticals, as recorded in our data.
Marius Pharmaceuticals is a funded company, having raised a total of $11.61M across 2 funding rounds to date. The company's 1st funding round was a Series B of $5.6M, raised on May 2019.
Marius Pharmaceuticals is dedicated to revolutionizing hormone health through science-backed therapies. The company addresses testosterone deficiency, impacting metabolic vitality and well-being for both men and women. Solutions are developed to improve conditions like obesity, type 2 diabetes, and menopausal symptoms in women. Research initiatives are supported to explore hormone imbalances across various comorbidities and patient populations. Innovative oral testosterone therapy, such as KYZATREX, is provided to treat adult men with low testosterone levels due to specific medical conditions.
Marius Pharmaceuticals's top competitors include Auxilium Pharmaceuticals, Microchips Biotech and Xanodyne Pharmaceuticals.
Marius Pharmaceuticals offers KYZATREX.
Marius Pharmaceuticals operates through Marius Pharmaceuticals.